Apolipoprotein C3 and necrotic core volume are correlated but also associated with future cardiovascular events

Sci Rep. 2022 Aug 25;12(1):14554. doi: 10.1038/s41598-022-18914-1.

Abstract

We aimed to clarify the relationship between apolipoprotein C3 (apo-C3) and the vascular composition of lesion plaque in stable coronary disease (SCD) before percutaneous coronary intervention (PCI), and to investigate major adverse cardiovascular events (MACEs) within 4 years. Data of 98 consecutive patients with SCD who underwent PCI between November 1, 2012, and March 10, 2015, were analyzed. Laboratory and virtual histology-intravascular ultrasound (VH-IVUS) examinations of culprit lesions were conducted before PCI. Patients were divided according to median apo-C3 into low apo-C3 (≤ 8.5 mg/dL) and high apo-C3 (> 8.5 mg/dL) groups. VH-IVUS data indicated that the percentage of necrotic core volume (%NC) was significantly higher in the high apo-C3 group than in the low apo-C3 group. Moreover, the %NC significantly correlated with the apo-C3 level (R = 0.2109, P = 0.037). Kaplan-Meier curve analysis revealed that freedom from MACEs exhibited a greater decrease in the high apo-C3 group than in the low apo-C3 group, and in the high %NC group than in the low %NC group. Multivariate Cox hazards analysis showed that the %NC and high apo-C3 were independent predictors of 4 year MACEs. Apo-C3 may be a useful marker of future MACEs in patients with SCD after PCI and contribute to %NC growth.

MeSH terms

  • Apolipoprotein C-III / metabolism*
  • Coronary Artery Disease* / metabolism
  • Coronary Artery Disease* / pathology
  • Humans
  • Necrosis / metabolism
  • Percutaneous Coronary Intervention / adverse effects
  • Plaque, Atherosclerotic / pathology
  • Ultrasonography, Interventional

Substances

  • Apolipoprotein C-III